Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by DavidRosenbergon Mar 08, 2023 10:39pm
47 Views
Post# 35327350

RE:How did Celsius holdings grow since Kevin joined them

RE:How did Celsius holdings grow since Kevin joined them<br />

It's difficult to predict the chances of success for any new product launch, as there are many factors that can influence the success or failure of a product in the market. However, Kevin Harrington's experience and track record as an entrepreneur and with Celsius holdings  m could certainly be valuable assets in guiding FSD Pharma in the development and launch of a new product to address alcoholism.
 
If FSD Pharma were to create a product to address alcoholism and Kevin Harrington were involved in guiding the company, it's likely that he would draw upon his experience in sales and marketing to help position the product in the market and reach its target audience. He may also be able to provide guidance on product development and innovation, based on his experience working with other companies in the health and wellness space.
 
Ultimately, the success of a new product launch would depend on many factors, including the quality and effectiveness of the product, the strength of the marketing and distribution strategy, and the competitive landscape in the market. However, having someone with Kevin Harrington's experience and expertise involved in the launch could certainly increase the chances of success.
<< Previous
Bullboard Posts
Next >>